** = Publikationen gelistet in SCI/SSCI/Pubmed
** de Yebenes, JG; Landwehrmeyer, B; Squitieri, F; Reilmann, R; Rosser, A; Barker, RA; Saft, C; Magnet, MK; Sword, A; Rembratt, A; Tedroff, J; MermaiHD study investigators
Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Neurol. 2011; 10(12):1049-1057
Doi: 10.1016/S1474-4422(11)70233-2
Web of Science
PubMed
FullText
FullText_MUG
** Reisinger, KM; Habermann, W; Hodl, AK; Magnet, M; Bonelli, RM
Dysphagia in Huntington's disease: A course analysis
J NEUROL NEUROSURG PSYCHIAT. 2008; 79: A17-A17.-EHDN Meeting; Sep 5-6, 2008; Lissabon, Portugal.
[Poster]
Web of Science
** Magnet, MK; Kapfhammer, HP; Bonelli, RM
Cabergoline in Huntington's disease: the first case report.
ACTA NEUROL SCAND. 2006; 113(5): 355-356.
Doi: 10.1111/j.1600-0404.2006.00583.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Magnet, MK; Hodl, AK; Hofmann, P; Kapfhammer, HP; Bonelli, RM; Habermann, W
Dysphagia in Huntington's disease
J NEUROL NEUROSURG PSYCHIAT. 2005; 76: -World Congress on Huntingtons Disease; SEP 10-13, 2005; Manchester, ENGLAND.
[Poster]
Web of Science
** Magnet, MK; Hodl, AK; Kapfhammer, HP; Bonelli, RM; Reisecker, F
MRI findings in Huntington's disease
J NEUROL NEUROSURG PSYCHIAT. 2005; 76: -World Congress on Huntingtons Disease; SEP 10-13, 2005; Manchester, ENGLAND.
[Poster]
Web of Science
** Magnet, MK; Bonelli, RM; Kapfhammer, HP
Amantadine in the akinetic-rigid variant of Huntington's disease.
ANN PHARMACOTHER. 2004; 38(7-8): 1194-1196.
Doi: 10.1345/aph.1E004
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar